The clinical value of p53 and the parameters of DNA-flow cytofluorometry in combination with clinical and morphological predictors in breast cancer

The clinical value of p53 and the parameters of DNA-flow cytofluorometry in combination with clinical and morphological predictors in breast cancer

The determination of mutant p53 and the basic parameters studied by DNA-flow cytofluorometry in combination with other clinical and morphological predictors may be used as additional prognostic criteria individually in each patient with breast cancer.

Saved in:
Bibliographic Details
Published in:Opukholi zhenskoĭ reproduktivnoĭ sistemy no. 2; pp. 44 - 46
Main Authors: L. K. Tsoi, V. N. Bogatyrev, V. P. Letyagin, Ya. V. Vishnevskaya, A. M. Platova
Format: Journal Article
Language:Russian
Published: ABV-press 01-08-2014
Subjects:
breast cancer
dna-flow cytofluorometry
early forms of breast cancer
mutant p53
prognostic factors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The determination of mutant p53 and the basic parameters studied by DNA-flow cytofluorometry in combination with other clinical and morphological predictors may be used as additional prognostic criteria individually in each patient with breast cancer.
ISSN:1994-4098
1999-8627
DOI:10.17650/1994-4098-2010-0-2-44-46